Mutational analysis of the mouse somatostatin receptor type 5 gene promoter

Endocrinology

Volumn 143, Issue 6, 2002, Pages 2268-2276

  Woodmansee, Whitney W ^a   Mouser, Rhonda L ^a   Gordon, David F ^a   Dowding, Janet M ^a   Wood, William M ^a   Chester Ridgway, E ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; NUCLEAR FACTOR; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL TYPE; CONTROLLED STUDY; GENE ACTIVITY; GENE DELETION; GENE MAPPING; HYPOPHYSIS CELL; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0036093291     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.6.8824     Document Type: Article

References (49)

1. Somatostatin
2. The role of somatostatin and its analogs in the diagnosis and treatment of tumors
3. Octreotide
4. Somatostatin analogue treatment of neuroendocrine tumours
5. Thyrotropin-secreting pituitary tumors
6. Octreotide therapy for thyroid stimulating hormone-secreting pituitary adenomas
7. Octreotide as primary therapy for acromegaly
8. Management of pituitary tumors
9. Mini review: The somatostatin receptor family
10. Somatostatin receptors
11. Molecular biology of somatostatin receptors
12. Somatostatin and its receptor family
13. 3 cells
14. Regulation of mouse somatostatin receptor type 2 gene expression by glucocorticoids
15. Genomic structure and transcriptional regulation of the human somatostatin receptor type 2
16. 1 cells
17. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells
18. Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen-responsiveness
19. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries
20. Thyroid hormone-induced expression of specific somatostatin receptor subtypes correlates with involution of the TtT-97 murine thyrotrope tumor
21. Thyroid hormones regulate the expression of somatostatin receptor subtypes in the rat pituitary
22. The effect of thyroid hormone and a long acting somatostatin analog on TtT-97 murine thyrotropic tumors
23. Cloning of the mouse somatostatin receptor subtype 5 gene: Promoter structure and function
24. DNA sequencing with chain terminating inhibitors
25. An α-subunit secreting cell line derived from a mouse thyrotropic tumor
26. Thyroid hormone regulates the mouse thyrotropin β-subunit gene promoter in transfected primary thyrotropes
27. Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells
28. The combination of Pit-1 and Pit-1T have a synergistic stimulatory effect on the thyrotropin-β subunit promoter by not the growth hormone or prolactin promoters
29. Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin β-subunit promoter
30. Transcriptional properties of Ptx1 and Ptx2 isoforms
31. Steroidogenic factor-1 and early growth response protein 1 act through two composite DNA binding sites to regulate luteinizing hormone β-subunit gene expression
32. Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone β gene transcription
33. Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice
34. A tale of three fingers: The family of mammalian Sp/XKLF transcription factors
35. Sp1 and thyroid hormone receptor differentially activate expression of human growth hormone and chorionic somatomammotropin genes
36. Overlapping Pit-1 and Sp1 binding sites are both essential to full rat growth hormone gene promoter activity despite mutually exclusive Pit-1 and Sp1 binding
37. Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification
38. Sp1, steroidogenic factor 1 (SF-1), and early growth response protein 1 (egr-1) binding sites form a tripartite gonadotropin-releasing hormone response element in the rat luteinizing hormone-beta gene promoter: An integral role for SF-1
39. Characterization of 5′ flanking region of rat somatostatin receptor sst2 gene: Transcriptional regulator elements and activation by Pitx1 and estrogen
40. Sequence analysis of the 5′-flanking promoter region of the human somatostatin receptor 5
41. Cloning of the gene encoding human somatostatin receptor 2: Sequence analysis of the 5′-flanking promoter region
42. Sequence analysis of the promoter region of the rat somatostatin receptor subtype 1 gene
43. Cloning, expression, pharmacology and tissue distribution of the mouse somatostatin receptor subtype 5
44. Characterization of the 5′-flanking promoter region of the rat somatostatin receptor subtype 3 gene
45. Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene
46. Dual regulation of somatostatin receptor subtype 1 gene expression by Pit-1 in anterior pituitary GH3 cells
47. The POU domain transcription factor Tst-1 activates somatostatin receptor 1 gene expression in pancreatic β-cells
48. Activation of somatostatin receptor II expression by transcription factors MIBP1 and SEF-2 in the murine brain
49. Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-β. Involvement of smad4